Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview        

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.2 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Obesity Incidence and Prevalence (2024), by Region

5.2 Anti-Obesity Drug Prescription Trends (2024), by Region

5.3 Obesity-Related Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2024

5.4 Regulatory and Reimbursement Trends (2024)

5.5 Drug Discontinuation and Adverse Event Rates (2024)

5.6 Public Awareness and Adoption Trends (2024)

6. Competitive Landscape

6.1 List of Major Companies By Region

6.2 Market Share Analysis By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion Plans and New Product Launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Anti-Obesity Drugs Market Segmentation By Type

7.1 Chapter Overview

7.2 Prescription Drugs

        7.2.1 Prescription Drugs Market Trend Analysis (2021-2032)

7.2.2 Prescription Drugs Market Size Estimates and Forecasts to 2032 (USD Billion)

7.3 OTC Drugs

       7.3.1 OTC Drugs Market Trends Analysis (2021-2032)

       7.3.2 OTC Drugs Market Size Estimates and Forecasts to 2032 (USD Billion)

8. Anti-Obesity Drugs Market Segmentation By Distribution Channel

8.1 Chapter Overview

8.2 Hospital Pharmacy

        8.2.1 Hospital Pharmacy Market Trends Analysis (2021-2032)

8.2.2 Hospital Pharmacy Market Size Estimates and Forecasts to 2032 (USD Billion)

8.3 Retail and Online Pharmacy

      8.3.1 Retail and Online Pharmacy Market Trends Analysis (2021-2032)

      8.3.2 Retail and Online Pharmacy Market Size Estimates and Forecasts to 2032 (USD Billion)

9. Regional Analysis

     9.1 Chapter Overview

     9.2 North America

9.2.1 Trends Analysis

9.2.2 North America Anti-Obesity Drugs Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.2.3 North America Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion) 

9.2.4 North America Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.2.5 USA

9.2.5.1 USA Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.2.5.2 USA Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.2.6 Canada

9.2.6.1 Canada Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.2.6.2 Canada Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.2.7 Mexico

9.2.7.1 Mexico Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.2.7.2 Mexico Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3 Europe

9.3.1 Trends Analysis

9.3.2 Europe Anti-Obesity Drugs Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.3.3 Europe Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion) 

9.3.4 Europe Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.5 Germany

9.3.5.1 Germany Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.5.2 Germany Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.6 France

9.3.6.1 France Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.6.2 France Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.7 UK

9.3.7.1 UK Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.7.2 UK Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.8 Italy

9.3.8.1 Italy Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.8.2 Italy Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.9 Spain

9.3.9.1 Spain Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.9.2 Spain Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.10 Poland

9.3.10.1 Poland Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.10.2 Poland Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.11 Turkey

9.3.11.1 Turkey Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.11.2 Turkey Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.3.12 Rest of Europe

9.3.12.1 Rest of Europe Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.3.12.2 Rest of Europe Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4 Asia Pacific

9.4.1 Trends Analysis

9.4.2 Asia Pacific Anti-Obesity Drugs Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.4.3 Asia Pacific Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion) 

9.4.4 Asia Pacific Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4.5 China

9.4.5.1 China Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.4.5.2 China Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4.6 India

9.4.5.1 India Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.4.5.2 India Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4.5 Japan

9.4.5.1 Japan Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.4.5.2 Japan Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4.6 South Korea

9.4.6.1 South Korea Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.4.6.2 South Korea Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4.7 Singapore

9.4.7.1 Singapore Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.4.7.2 Singapore Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

8.4.8 Australia

8.4.8.1 Australia Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

8.4.8.2 Australia Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.4.9 Rest of Asia Pacific

9.4.9.1 Rest of Asia Pacific Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.4.9.2 Rest of Asia Pacific Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.5 Middle East & Africa

9.5.1 Trends Analysis

9.5.2 Middle East & Africa Anti-Obesity Drugs Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.5.3 Middle East & Africa Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion) 

9.5.4 Middle East & Africa Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.5.5 UAE

9.5.5.1 UAE Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.5.5.2 UAE Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.5.6 Saudi Arabia

9.5.6.1 Saudi Arabia Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.5.6.2 Saudi Arabia Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.5.7 Qatar

9.5.7.1 Qatar Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.5.7.2 Qatar Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.5.8 South Africa

9.5.8.1 South Africa Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.5.8.2 South Africa Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.5.9 Middle East & Africa

9.5.9.1 Middle East & Africa Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.5.9.2 Middle East & Africa Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.6 Latin America

9.6.1 Trends Analysis

9.6.2 Latin America Anti-Obesity Drugs Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.6.3 Latin America Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion) 

9.6.4 Latin America Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.6.5 Brazil

9.6.5.1 Brazil Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.6.5.2 Brazil Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.6.6 Argentina

9.6.6.1 Argentina Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.6.6.2 Argentina Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

9.6.7 Rest of Latin America

9.6.7.1 Rest of Latin America Anti-Obesity Drugs Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)

9.6.7.2 Rest of Latin America Anti-Obesity Drugs Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)

10. Company Profiles

           10.1 Novo Nordisk A/S

                          10.1.1 Company Overview

10.1.2 Financial

10.1.3 Product / Services Offered

10.1.4 SWOT Analysis

           10.2 GlaxoSmithKline plc

                           10.2.1 Company Overview

10.2.2 Financial

10.2.3 Product/ Services Offered

10.2.4 SWOT Analysis

10.3 VIVUS LLC

              10.3.1 Company Overview

10.3.2 Financial

10.3.3 Product/ Services Offered

10.3.4 SWOT Analysis

10.4 Currax Pharmaceuticals LLC

             10.4.1 Company Overview

10.4.2 Financial

10.4.3 Product/ Services Offered

10.4.4 SWOT Analysis

10.5 F. Hoffmann-La Roche Ltd

             10.5.1 Company Overview

10.5.2 Financial

10.5.3 Product/ Services Offered

10.5.4 SWOT Analysis

10.6 Pfizer Inc.

             10.6.1 Company Overview

10.6.2 Financial

10.6.3 Product/ Services Offered

10.6.4 SWOT Analysis

10.7 Boehringer Ingelheim International GmbH

             10.7.1 Company Overview

10.7.2 Financial

10.7.3 Product/ Services Offered

10.7.4 SWOT Analysis

10.8 Eli Lilly and Company

             10.8.1 Company Overview

10.8.2 Financial

10.8.3 Product/ Services Offered

10.8.4 SWOT Analysis

10.9 Amgen Inc.

             10.9.1 Company Overview

10.9.2 Financial

10.9.3 Product/ Services Offered

10.9.4 SWOT Analysis

10.10 Rhythm Pharmaceuticals

             10.10.1 Company Overview

10.10.2 Financial

10.10.3 Product/ Services Offered

10.10.4 SWOT Analysis

11. Use Cases and Best Practices

12. Conclusion